Supplementary Data: Nanoparticle mRNA Vaccine Efficacy in Mouse Model

36.5 KB of supplementary data in XLSX format, published on figshare under CC-BY-4.0 by Tian Zeng on 2026-03 18. The data likely supports a study on a dendritic cell-targeting mRNA vaccine for hepatocellular carcinoma, reporting a tumor inhibition ratio of 99.8% in a Hepa1-6 tumor-bearing mouse model.

Use Cases

• Analyze nanoparticle formulation efficacy based on the described poly T-modified PLGA carrier.
• Model immune response activation based on the reported endoplasmic reticulum membrane camouflage.
• Evaluate endosomal escape properties based on the described biomimetic vaccine design.
• Compare tumor inhibition outcomes based on the reported 99.8% TIR in the mouse model.

Strengths

• File size is precisely 36.5 KB, indicating a focused dataset.
• Dataset is licensed under the permissive CC-BY-4.0.
• Last update date is explicitly recorded as 2026-03-18.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data may reflect experimental bias inherent to the specific mouse model study.

Provenance

Source

figshare, author Tian Zeng.

Collection Method

Likely contains experimental results from a biomedical study.

Time Range

Temporal coverage is not specified in the metadata.

Freshness

Last updated 2026-03-18 01:47:05; freshness should be verified.

Geography

Spatial coverage is not specified in the metadata.